Description
A potent NS3/4A protease inhibitor (Ki = 0.36 nM); inhibits HCV viral replication (EC50 = 7.8 nM); effective against the HCV genotypes 1a and 1b in biochemical assays; works synergistically with IFN-α or NM-107 in replicon cells; works additively with ribavirin in replicon cells,
Formal name: (2R,3aR,10Z,11aS,12aR,14aR)-N-(cyclopropylsulfonyl)-2,3,3a,4,5,6,7,8,9,11a,12,13,14,14a-tetradecahydro-2-[[7-methoxy-8-methyl-2-[4-(1-methylethyl)-2-thiazolyl]-4-quinolinyl]oxy]-5-methyl-4,14-dioxo-cyclopenta[c]cyclopropa[g][1,6]diazacyclotetradecine-12a(1H)-carboxamide, sodium salt
Synonyms:
Molecular weight: 749.9
CAS: 1241946-89-3
Purity: ≥98%
Formulation: A crystalline solid
Product Type|Biochemicals|Antivirals|Protease Inhibitors||Product Type|Biochemicals|Small Molecule Inhibitors|MMPs||Product Type|Biochemicals|Small Molecule Inhibitors|Peptidases & Proteases||Research Area|Immunology & Inflammation||Research Area|Infectious Disease|Viral Diseases|Hepatitis